In most cases the serum levels of adipokines released in HBV infected patients resemble the levels reported in other non-HBV infected patients with NAFLD, as seen in the cases of visfatin, leptin and resisitin. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.